OGFRL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.092340E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.239000E-03
Normal-vs-Stage2
2.179600E-02
Normal-vs-Stage3
2.921700E-03
Normal-vs-Stage4
2.308500E-02
Stage1-vs-Stage2
3.133400E-01
Stage1-vs-Stage3
9.742600E-01
Stage1-vs-Stage4
3.786200E-01
Stage2-vs-Stage3
3.125600E-02
Stage2-vs-Stage4
9.427400E-01
Stage3-vs-Stage4
2.493200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.092250E-02
Normal-vs-AfricanAmerican
2.270000E-01
Normal-vs-Asian
8.407900E-04
Caucasian-vs-AfricanAmerican
5.347400E-01
Caucasian-vs-Asian
4.429800E-01
AfricanAmerican-vs-Asian
4.707400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.398660E-03
Normal-vs-Female
4.953900E-02
Male-vs-Female
8.554200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.106200E-02
Normal-vs-Age(41-60Yrs)
7.856400E-03
Normal-vs-Age(61-80Yrs)
1.582280E-02
Normal-vs-Age(81-100Yrs)
3.960300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.753000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.146200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.755400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.075400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.991000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.710400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.234800E-04
Normal-vs-Daily Drinker
1.360240E-03
Normal-vs-Weekly Drinker
2.798400E-02
Normal-vs-Occasional Drinker
5.396700E-03
Normal-vs-Social Drinker
5.311700E-02
Non Drinker-vs-Daily Drinker
2.891600E-01
Non Drinker-vs-Weekly Drinker
5.216400E-01
Non Drinker-vs-Occasional Drinker
7.190000E-01
Non Drinker-vs-Social Drinker
2.800000E-01
Daily Drinker-vs-Weekly Drinker
2.135400E-01
Daily Drinker-vs-Occasional Drinker
6.063000E-01
Daily Drinker-vs-Social Drinker
8.285500E-02
Weekly Drinker-vs-Occasional Drinker
4.654800E-01
Weekly Drinker-vs-Social Drinker
6.711600E-01
Occasional Drinker-vs-Social Drinker
2.331800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.805800E-01
Normal-vs-Grade 2
5.061800E-01
Normal-vs-Grade 3
6.422200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.952200E-02
Grade 1-vs-Grade 3
7.797500E-02
Grade 1-vs-Grade 4
9.805800E-01
Grade 2-vs-Grade 3
7.257800E-01
Grade 2-vs-Grade 4
5.061800E-01
Grade 3-vs-Grade 4
6.422200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.361300E-03
Normal-vs-NonDiabetic
9.791900E-04
Diabetic-vs-NonDiabetic
4.757200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.612100E-04
Normal-vs-NoPancreatitis
2.701500E-03
Pancreatitis-vs-NoPancreatitis
3.310800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.843630E-04
Normal-vs-N1
3.058100E-02
N0-vs-N1
2.817700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.360400E-02
Normal-vs-TP53-NonMutant
1.981740E-02
TP53-Mutant-vs-TP53-NonMutant
9.812200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
